Advertisement

RMD

ResMed Inc.

Healthcare · USD

Set alert

Price alert · RMD

All alert types
229.94 USD -22.89 -9.05%
As of Oct 30, 2026 Extended hours 229.94 0.00%
Bid
228.75 × 200
Ask
230.11 × 600
228.54 Day range 248.05
182.82 52-week range 275.96
YTD
-4.54%
1 year
-8.85%
Open
246.56
Prev close
252.83
Mkt cap
32.34B
Vol
3.47M
Avg vol
1.32M
EPS
10.43
P/E
22.05
Div yield
1.04%
More statistics
Low
228.54
High
248.05
Forward P/E
17.34
Beta
0.75
Short ratio
10.34
Inst. own
73.30%
Dividend
2.64
Ex-div date
Aug 19, 2026
Earnings
Jan 28, 2027
50-d avg
231.77
200-d avg
225.03
1y target
251.52

5D chart

Chart tools
Interval
RMD five-day price chart228.3235.0241.7248.3255.0Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
32.32B
Enterprise value
35.83B
Trailing P/E
22.03
Forward P/E
17.34
PEG ratio
1.35
Price / sales
5.72
Price / book
5.03
EPS (TTM)
10.43
Beta
0.75
Dividend yield
1.04%
Payout ratio
23.01%
Profit margin
26.95%
Revenue (TTM)
5.65B
Revenue growth
8.60%
Free cash flow
939.25M
Total cash
1.47B
Total debt
825.92M
Return on equity
24.27%
Shares outstanding
140.64M
Short % of float
8.51%
50-day average
231.77
200-day average
225.03

Analyst view

Consensus: buy

Buy
Price target (mean) 251.52 +9.4% upside
Target (low)
175.00
Target (mean)
251.52
Target (high)
320.00
Ratings (0m) 20 9 buy · 10 hold · 1 sell
  • Strong buy2
  • Buy7
  • Hold10
  • Sell1
  • Strong sell0

Next earnings

Jan 28, 2027

Expected Jan 28, 2027. Consensus EPS estimate 3.02.

Earnings history

Financials — quick view

All financials
RMD Revenue — quarterly 1.46B
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
RMD Net income — quarterly 383.43M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
RMD EPS — quarterly 2.65
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

RMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 28, 2027Dec 30, 20263.03———
Oct 29, 2026Sep 30, 20262.692.91+0.22+8.18%
Aug 6, 2026Jun 30, 20262.892.95+0.06+2.08%
Apr 30, 2026Mar 31, 20262.802.86+0.06+2.14%
Jan 29, 2026Dec 31, 20252.742.81+0.07+2.55%
Oct 30, 2025Sep 30, 20252.512.55+0.04+1.59%

Upgrades / downgrades

RMD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026RBC CapitalmainOutperformOutperform
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 30, 2026KeybancmainOverweightOverweight
Sep 15, 2026RBC CapitalupSector PerformOutperform
Aug 31, 2026KeybancmainOverweightOverweight
Aug 19, 2026Rothschild & Coinit—Neutral

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
resmed.com

News

Your note

Sign in to keep a note on RMD — it syncs with the Stock Master app.

Insider holders

RMD insider holders
InsiderRelationLatest transactionDateShares held
BURT CAROL JDirectorStock Award(Grant)Nov 19, 202518,816
FARRELL MICHAEL JChief Executive OfficerSaleSep 7, 2026468,346
FARRELL MICHAEL J.Chief Executive OfficerSaleOct 6, 2026481,893
FARRELL PETER CRAIGDirectorSaleAug 4, 202652,773
GHOSHAL KAUSHIKOfficerSaleMar 9, 202519,353
LEONG JUSTINOfficerStock Award(Grant)Aug 13, 202635,489

Institution ownership

RMD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.76%12,317,1942.83BJun 29, 2026
Vanguard Capital Management LLC6.74%9,474,1292.18BJun 29, 2026
Vanguard Portfolio Management LLC5.63%7,913,6611.82BJun 29, 2026
State Street Corporation4.75%6,680,7351.54BJun 29, 2026
Geode Capital Management, LLC3.09%4,352,3201.00BJun 29, 2026
Bank Of New York Mellon Corporation2.98%4,197,610964.69MJun 29, 2026

Fund ownership

RMD fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.27%4,605,3091.06BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.67%3,758,092863.68MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.23%3,143,005722.33MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.37%1,922,453441.82MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.34%1,882,957432.74MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Growth Index Fund1.33%1,866,016428.85MJun 29, 2026
Advertisement